135 related articles for article (PubMed ID: 35045526)
1. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
Polvani S; Martignano F; Scoccianti G; Pasqui A; Palomba AR; Conticello S; Galli A; Palchetti I; Caporalini C; Antonuzzo L; Campanacci DA; Pillozzi S
Anticancer Drugs; 2022 Mar; 33(3):278-285. PubMed ID: 35045526
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
4. The critical roles of lncRNAs in the development of osteosarcoma.
Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M
Biomed Pharmacother; 2021 Mar; 135():111217. PubMed ID: 33433358
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p in human osteosarcoma.
Liu W; Liu PC; Ma K; Wang YY; Chi QB; Yan M
Cell Biochem Funct; 2020 Oct; 38(7):886-894. PubMed ID: 32196715
[TBL] [Abstract][Full Text] [Related]
7. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
Zhang CL; Zhu KP; Ma XL
Cancer Lett; 2017 Jun; 396():66-75. PubMed ID: 28323030
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA
Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
[TBL] [Abstract][Full Text] [Related]
9. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
Han Z; Shi L
Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
12. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
Zhang X; Du K; Lou Z; Ding K; Zhang F; Zhu J; Chang Z
Int J Biol Sci; 2019; 15(7):1460-1471. PubMed ID: 31337976
[TBL] [Abstract][Full Text] [Related]
13. Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance.
Qin S; Wang Y; Ma C; Lv Q
Eur J Med Res; 2023 Sep; 28(1):354. PubMed ID: 37717007
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a.
Wang Y; Kong D
Cell Physiol Biochem; 2018; 45(2):844-855. PubMed ID: 29414815
[TBL] [Abstract][Full Text] [Related]
15. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
20. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
